SCHEMBL30689335

SCHEMBL30689335

CC(=O)OCc1nc(-c2ccc(Oc3nnc(C)s3)cc2)no1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ SIRT2 Q8IXJ6 1/20 0.45
▸ ACACB O00763 1/20 0.44
▸ FFAR1 O14842 2/20 0.44
▸ GSTP1 P09211 6/20 0.43
▸ ATM Q13315 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ MAPT P10636 4/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689367 0.84 NOTUM (0.50) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL30689384 0.82 TSHR (0.42) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL30689393 0.81 LMNA (0.43) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL8892261 0.79 LMNA (0.64) LMNARAB9ATSHRSIRT2ATM
SCHEMBL30689309 0.77 LMNA (0.39) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL5351217 0.75 SIRT2 (0.73) LMNARAB9ATSHRSIRT2FFAR1
SCHEMBL30689308 0.74 MITF (0.36) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL24922866 0.71 SIRT2 (0.47) LMNARAB9ATSHRSIRT2FFAR1
SCHEMBL1313507 0.69 SPHK1 (0.61) SIRT2FFAR1
SCHEMBL19012092 0.67 ACLY (0.47) LMNASIRT2FFAR1GSTP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback